Other Events ·
Valion Bio, Inc. filed an amended 8-K to disclose the final certified voting results from its Special Meeting of…
VBIOValion Bio, Inc.
Valion Bio, Inc. filed an amended 8-K to disclose the final certified voting results from its Special Meeting of Stockholders held on August 14, 2026. The company reported that stockholders approved Proposal No. 1, granting the Board discretionary authority to effect a reverse stock split of common shares at a ratio between 1-for-5 and 1-for-50 within twelve months. This proposal received 1,243,530 votes in favor against 697,127 opposed, with approximately 48.21% of outstanding common shares represented. Proposal No. 2 to adjourn the meeting was also approved but not utilized as the primary objective was achieved. Valion Bio, Inc. operates in the biotechnology industry.